Axiostat receives US FDA clearance

US FDA granted 510(k) clearance to Axiostat Chitosan Hemostatic Dressing, which is cleared as an over-the-counter product to stop external bleeding. In the US, the product will be marketed by Advamedica Inc, headquartered in Boston.

Axiostat Hemostatic Dressing is a patented Chitosan biopolymer-based product which has prevented countless deaths due to bleeding in military battlefields, hospitals, and on roads worldwide. The innovative first-aid dressing stops uncontrollable bleeding within just two-three minutes of its application.

Axiostat has earlier received CE mark approval in the European Union. The award-winning product is being used in the frontline battlefield by many defence forces across the globe.

axio_admin

all author posts

YOU ARE LEAVING THE ADVAMEDICA US SITE.

If you continue, you will leave this site and go to a non-US site.

Some of the products on the other site may not be approved in the United States.”

Contact us

YOU ARE LEAVING THE ADVAMEDICA US SITE.

If you continue, you will leave this site and go to a non-US site.

Some of the products on the other site may not be approved in the United States.”